Cancer Panel Assay for Precision Oncology Clinic: Results from a 1-Year Study

Author:

Kwon Dohee,Kim Binnari,Shin Hyeong Chan,Kim Eun Ji,Ha Sang Yun,Jang Kee-Taek,Kim Seung Tae,Lee Jeeyun,Kang Won Ki,Park Joon Oh,Kim Kyoung-Mee

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls;Horak;ESMO Open,2016

2. Single-center experience with a targeted next generation sequencing assay for assessment of relevant somatic alterations in solid tumors;Paasinen-Sohns;Neoplasia,2017

3. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology;Li;and College of American Pathologists J Mol Diagn,2017

4. Identification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS);Al-Kateb;Mol Oncol,2015

5. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing;Wagle;Cancer Discov,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3